The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing financial toxicity in insured patients with multiple myeloma.
 
Scott F. Huntington
Stock and Other Ownership Interests - Exelixis (I); Geron (I); OncoSec
 
Brendan M. Weiss
Consulting or Advisory Role - Janssen; Millennium
Research Funding - Janssen; Onclave Therapeutics
 
Dan T. Vogl
Consulting or Advisory Role - Amgen; Celgene
Research Funding - Acetylon Pharmaceuticals; GlaxoSmithKline; Millennium
 
Adam D. Cohen
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Research Funding - Bristol-Myers Squibb
 
Alfred L. Garfall
Travel, Accommodations, Expenses - Idera
 
Jalpa A. Doshi
Employment - Merck (I); Pfizer (I)
Stock and Other Ownership Interests - Merck (I); Pfizer (I)
Consulting or Advisory Role - Alkermes; Boehringer Ingelheim; Forest Laboratories; Ironwood Pharmaceuticals; Shire
Research Funding - Amgen; Humana; Merck; National Pharmaceutical Council; Pfizer; PhRMA Foundation
 
Edward A. Stadtmauer
Consulting or Advisory Role - Celgene